SciSparc

SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for treatment of central nervous system disorders. The company has four drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer's Disease and Agitation, Autism Spectrum Disorder, and two in pre-clinical studies for Status Epilepticus and Chronic Pain.

SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for treatment of central nervous system disorders. The company's pipeline includes four drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer's Disease and Agitation, Autism Spectrum Disorder, and two in pre-clinical studies for Status Epilepticus and Chronic Pain.

• 2021.02

  Reported2021.02.11

  SciSparc rebrands and changes its company name[4]SciSparc 更名并进行品牌重塑prnewswire.com

  SciSparc announced that it had changed its company name from Therapix Biosciences Ltd. to SciSparc Ltd. as part of a rebranding that also included a new logo and share symbol.

Read more

1. 1SciSparc – Groundbreaking Therapiesscisparc.com
2. 2About – SciSparcscisparc.com
3. 3Product – SciSparcscisparc.com
4. 4SciSparc 更名并进行品牌重塑prnewswire.com
5. 5SciSparc Announces Completion of Corporate Rebranding and Launch of New Websiteprnewswire.com